Chronic urticaria patient perspective (CUPP): The first validated tool for assessing quality of life in clinical practice
The Journal of Allergy and Clinical Immunology: In Practice Sep 18, 2017
Baiardini I, et al. - For assessment of patients with chronic urticaria (CU) in clinical practice, experts validated the Chronic Urticaria Patient Perspective (CUPP). This study outlined CUPP as a simple 10-question tool with good psychometric properties. This tool rendered a valid, reliable, and standardized measurement of health-related quality of life (HRQoL) in patients with CU.
Methods
- From candidate items identified by following an iterative process in a retrospective analysis of 249 Chronic Urticaria Quality of Life Questionnaire questionnaires, a provisional CUPP was developed.
- Further to this, the psychometric properties of the CUPP were tested on a sample of patients enrolled in 13 Italian centers.
Results
- 152 patients were incorporated in the validation phase.
- Satisfactory internal consistency (Cronbach's alpha values of 0.76 at visit 1 and 0.90 at visit 2), good criteria, and discriminative and convergent validity were exhibited by the 10-item version of the CUPP.
- In 34 patients, reliability was assessed with no changes in health (Global Rating Scale = 0 at visit 2) and was satisfactory (CCC [concordance correlation coefficient] = 0.9).
- Results indicated an association of changes in CUPP scores with changes in Urticaria Activity Score (UAS)-Hive count (r = 0.36, P < .001), UAS-Itch severity (r = 0.48, P < .001), and UAS-Total score (r = 0.342, P < .001).
- All of these indicated good responsiveness.
- 1.5 was the minimal important difference.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries